Structures by: Frydenvang K.
Total: 40
Metformin acetate
C4H12N5,C2H3O2
Journal of natural products (2017) 80, 10 2830-2834
a=9.8260(6)Å b=8.8711(7)Å c=10.6841(7)Å
α=90.00° β=90.834(3)° γ=90.00°
Schizine A
C24H25NO5
Journal of natural products (2015) 78, 5 1165-1168
a=8.7130(6)Å b=11.5100(8)Å c=20.2530(13)Å
α=90.000° β=90.000° γ=90.000°
C14H30I2N2O4
C14H30I2N2O4
Acta Crystallographica Section B (1996) 52, 1 184-193
a=12.803(3)Å b=8.165(2)Å c=9.612(2)Å
α=90.0° β=98.09(2)° γ=90.0°
C7H16ClNO2
C7H16ClNO2
Acta Crystallographica Section B (1996) 52, 1 184-193
a=9.890(2)Å b=15.324(6)Å c=6.302(3)Å
α=90.0° β=90.0° γ=90.0°
C6H15BrN2O2
C6H15BrN2O2
Acta Crystallographica Section B (1996) 52, 1 184-193
a=10.350(4)Å b=13.028(2)Å c=6.8160(10)Å
α=90.0° β=90.0° γ=90.0°
C6H15ClN2O2
C6H15ClN2O2
Acta Crystallographica Section B (1996) 52, 1 184-193
a=10.179(3)Å b=12.781(4)Å c=6.713(2)Å
α=90.0° β=90.0° γ=90.0°
C7H16INO3
C7H16INO3
Acta Crystallographica Section B (1996) 52, 1 184-193
a=10.2670(10)Å b=15.305(7)Å c=6.873(2)Å
α=90.0° β=90.0° γ=90.0°
C6H15IN2O2
C6H15IN2O2
Acta Crystallographica Section B (1996) 52, 1 184-193
a=5.919(2)Å b=12.573(4)Å c=13.643(2)Å
α=90.0° β=96.46(2)° γ=90.0°
L-(-)Ephedrine hemihydrate
C10H16NO1.5
Journal of Applied Crystallography (2001) 34, 2 203
a=7.3105(12)Å b=11.1878(6)Å c=23.979(4)Å
α=90.00° β=90.00° γ=90.00°
L-(-)Ephedrine hemihydrate
C10H16NO1.5
Journal of Applied Crystallography (2001) 34, 2 203
a=7.3188(4)Å b=11.2018(6)Å c=24.0156(14)Å
α=90.00° β=90.00° γ=90.00°
C16H26N2O4
C16H26N2O4
Acta Crystallographica Section C (1994) 50, 4 617-623
a=21.438(3)Å b=8.1610(10)Å c=21.655(6)Å
α=90.° β=109.98(2)° γ=90.°
C10H22N2O5
C10H22N2O5
Acta Crystallographica Section C (1994) 50, 4 617-623
a=9.997(2)Å b=10.347(2)Å c=12.6800(10)Å
α=90.° β=90.° γ=90.°
C18H32N2O6
C18H32N2O6
Acta Crystallographica Section C (1994) 50, 4 617-623
a=7.951(2)Å b=10.6133(9)Å c=23.421(4)Å
α=90.° β=90.° γ=90.°
C9H19NO7
C9H19NO7
Acta Crystallographica Section C (1994) 50, 4 617-623
a=6.2280(10)Å b=6.8190(10)Å c=7.4940(10)Å
α=95.42(2)° β=99.480(10)° γ=108.990(10)°
C5H14N1O1,C6H2N3O7
C5H14N1O1,C6H2N3O7
Acta Crystallographica Section C (1992) 48, 7 1343-1345
a=6.7895(9)Å b=22.054(2)Å c=9.7130(10)Å
α=90° β=103.500(10)° γ=90°
C12H16O5S
C12H16O5S
Acta Crystallographica Section C (1992) 48, 7 1341-1343
a=20.301(5)Å b=8.952(2)Å c=14.707(6)Å
α=90° β=90° γ=90°
C9H18N1O2,I1
C9H18N1O2,I1
Acta Crystallographica Section C (1992) 48, 3 469-474
a=12.791(2)Å b=13.097(2)Å c=7.4390(9)Å
α=90° β=90° γ=90°
C9H18N1O2,C6H2N3O7
C9H18N1O2,C6H2N3O7
Acta Crystallographica Section C (1992) 48, 3 469-474
a=6.584(3)Å b=23.127(6)Å c=11.962(3)Å
α=91.02(2)° β=104.76(3)° γ=90.37(3)°
2-Ethyl-3-(3-pyridyl)isoxazolin-5-one
C10H10N2O2
Acta Crystallographica Section C (1996) 52, 8 2102-2105
a=7.571(1)Å b=7.1610(7)Å c=16.535(2)Å
α=90° β=91.81(1)° γ=90°
O-Methyl-THPO hydrochloride
C7H11N2O21,Cl1
Acta Crystallographica Section C (1995) 51, 10 2053-2057
a=19.746(5)Å b=12.403(3)Å c=7.254(2)Å
α=90.00° β=100.57(2)° γ=90.00°
(dl)-trans-3-Hydroxy-5-iodomethyl-2,2-diphenyl-tetrahydrofuran
C17H17O2I
Acta Crystallographica Section C (1993) 49, 10 1837-1840
a=12.764(2)Å b=5.768(2)Å c=20.129(5)Å
α=90° β=96.18(2)° γ=90°
(dl)-trans-N,N,N-trimethyl-(3-hydroxy-2,2-diphenyl-5-tetrahydrofuryl)- methylammonium iodide
C20H26O2N1,I1
Acta Crystallographica Section C (1993) 49, 10 1837-1840
a=10.599(2)Å b=9.270(3)Å c=19.641(4)Å
α=90.0° β=96.170(10)° γ=90.0°
(-)-muscarone iodide
C9H18NO21,I1
Acta Crystallographica Section C (1993) 49, 10 1834-1837
a=12.7080(10)Å b=13.1310(10)Å c=7.4440(10)Å
α=90.0° β=90.0° γ=90.0°
Muscarine picrate
C9H20N1O21,C6H2N3O71
Acta Crystallographica Section C (1993) 49, 5 985-990
a=7.742(2)Å b=8.886(2)Å c=13.101(3)Å
α=97.39(2)° β=94.35(2)° γ=91.42(2)°
1-Methyl-1-hydroxyurea
C2H6N2O2
Acta Crystallographica Section C (1993) 49, 5 1018-1022
a=5.2049(9)Å b=23.375(4)Å c=13.155(3)Å
α=90.0° β=90.0° γ=90.0°
3-Methyl-1-hydroxyurea
C2H6N2O2
Acta Crystallographica Section C (1993) 49, 5 1018-1022
a=8.2020(10)Å b=7.0810(10)Å c=7.3160(10)Å
α=90.0° β=101.378(9)° γ=90.0°
Muscarine tetraphenylborate
C9H20N1O21,C24H20B11
Acta Crystallographica Section C (1993) 49, 5 985-990
a=9.936(2)Å b=30.210(5)Å c=9.7710(10)Å
α=90° β=111.340(10)° γ=90°
1-(1-Cyanocyclohexyl)-1-hydroxy-3-phenylurea
C14H17N3O2
Acta Crystallographica Section C (1997) 53, 8 1091-1093
a=10.0301(6)Å b=11.7403(7)Å c=11.7660(7)Å
α=95.559(5)° β=90.617(5)° γ=97.323(5)°
(-)(R)-5,5-Dimethylmorpholinyl-2-Acetic Acid Ethyl Ester Hydrochloride
C10H20NO31,Cl1
Acta Crystallographica Section C (1997) 53, 8 1088-1091
a=7.3930(10)Å b=8.827(2)Å c=19.907(3)Å
α=90.00° β=90.00° γ=90.00°
The Muscarinic Antagonist, 8,8-Dimethyl-3',3'-Diphenyl-spiro[8- azoniabicyclo[3.2.1]octane-3,2'-[1,3]-dioxolane]-4'-one iodide (BVT44Me).
C23H26NO31,I1
Acta Crystallographica Section C (1995) 51, 12 2644-2647
a=14.615(3)Å b=14.625(3)Å c=10.330(2)Å
α=90.00° β=107.67(2)° γ=90.00°
N-acetyl-N,O-di(propylcarbamoyl)hydroxylamine
C10H19N3O4
Acta Crystallographica Section C (1996) 52, 2 387-390
a=4.944(2)Å b=13.005(2)Å c=20.234(3)Å
α=85.07(1)° β=89.71(2)° γ=79.45(2)°
Ethoxycarbonylcholine Picrate Hemihydrate
C8H18NO31,C6H2N3O71,0.5(H2O)
Acta Crystallographica Section C (1994) 50, 11 1839-1841
a=11.623(3)Å b=7.432(2)Å c=21.197(5)Å
α=90.00° β=102.86(2)° γ=90.00°
C17H23NO2S
C17H23NO2S
The Journal of Organic Chemistry (2020)
a=25.6686(15)Å b=6.3122(4)Å c=11.3113(6)Å
α=90° β=115.585(4)° γ=90°
C13H14ClN
C13H14ClN
The Journal of Organic Chemistry (2020)
a=10.2971(4)Å b=5.3701(2)Å c=10.6919(4)Å
α=90° β=94.959(2)° γ=90°
C99H108N6O8,C7H8,2.411(C2H3N)
C99H108N6O8,C7H8,2.411(C2H3N)
The Journal of organic chemistry (2019) 84, 7 3762-3779
a=11.242(3)Å b=40.833(8)Å c=11.278(2)Å
α=90.00° β=111.848(6)° γ=90.00°
(S)-2-benzyl-1-(4-nitrobenzenesulfonyl)aziridine
C14H12N2O4S
Journal of Organic Chemistry (2008) 73, 3566-3569
a=6.8140(5)Å b=7.4770(7)Å c=13.4630(9)Å
α=90.000° β=95.487(5)° γ=90.000°
(S)-2-(cyclohexylmethyl)-1-(4-nitrobenzenesulfonyl)aziridine
C15H20N2O4S
Journal of Organic Chemistry (2008) 73, 3566-3569
a=6.7612(9)Å b=10.0124(11)Å c=12.1054(14)Å
α=80.571(10)° β=87.771(9)° γ=81.457(12)°
Amlodipine besylate dihydrate
C26H35ClN2O10S
Crystal Growth & Design (2010) 10, 12 5279
a=19.1100(17)Å b=9.6240(9)Å c=16.6930(18)Å
α=90.000(10)° β=106.690(9)° γ=90.000(10)°
Amlodipine besylate dihydrate
C26H35ClN2O10S
Crystal Growth & Design (2010) 10, 12 5279
a=18.892(2)Å b=9.5070(6)Å c=16.357(3)Å
α=90.000° β=105.285(12)° γ=90.000°
Amlodipine besylate monohydrate
C20H26ClN2O5,C6H5SO3,H2O
Crystal Growth & Design (2010) 10, 12 5279
a=17.689(2)Å b=17.533(7)Å c=36.843(11)Å
α=90.0° β=90.182(17)° γ=90.0°